\centered **Second Product Development Agreement**

Party A Yangling Dongke Maidisen Pharmaceutical Co.,Ltd

Party B Shaanxi [[Organization 1 Name]]

Based on the rule of CONTRACT LAW OF THE PEOPLE'S REPUBLIC OF CHINA, the two side made the following Second Product Development Agreement after consultations.

^^^About the content and the requirements of the R&D project

According to the National Drug Registration and Good Non-clinical Laboratory Practice, by [[Date 1: Date]],Party B has to complete the studies on production technology（including the study on extraction process, on technology of purification and on Molding Process）; studies on quality standard (including studies on TLC Content and on Content Determination); studies on stability ( including the studies on accelerated stability and on long-term stability) and also provide research material and original records.

^^^Responsibilities of the two sides  
Part A shall 
^Pay for the total expense on the research project according to the agreement.

^Provide the design of the project and the crude material of drugs needed in the research.

^Have a technical director involved in the project and participating the whole study process.

Party B shall 
^Conduct the research with the design of the project given by Party A to carry on the studies on production technology, on quality standard and on stability.

^Be responsible for the technology statistics, data collation and preparation of raw material.

^Be responsible for the test site, equipment and technical personnel.

^^^Deadline, place and means for filing the technical data,

Prior to [[Date 2: Date]], Party B should hand in the results of the research and the technology statistics in the form of paper document and in electronic form.

Ⅳ. Amount of the R&D, expenses and payment method.

^Party A paid Party B the total amount of expense on the second product development 920,000 RMB, among which 400,000 RMB on production technology,300,000 RMB on quality standard improvement and 220,000 RMB on stability.

^Payment method: the technical personnel in the R&D Department of Party A will submit applications for payment to the Financial Department according to the process of the research.

^Amount of the R&D: with the 11 products provided by Party A

^Others 
^The technical documents and the intellectual property of this project belongs to Party A. Party B must keep secret about the process of the R&D project.

^This Agreement entered into force upon signature by both parties.

^There are our copies of the Agreement, two for each party.

^The other outstanding issues can be resolved through mutual consultation.

Party A Yangling Dongke Maidisen Pharmaceutical Co.,Ltd

Responsible person:
**/s/ Xia Chuantao**
Xia Chuantao

Party B Shaanxi [[Organization 1 Name]]

Responsible person:
**/s/ [[Person 1 First Name]] [[Person 1 Last Name]]**
[[Person 1 First Name]] [[Person 1 Last Name]]         [[Date 3: Date]]